Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    5201 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 31
    5202 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 57
    5203 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 3
    5204 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 29
    5205 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 72
    5206 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Poland 46
    5207 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 57
    5208 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 58
    5209 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 31
    5210 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 47
    5211 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 64
    5212 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 46
    5213 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 40
    5214 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 60
    5215 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 65
    5216 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 68
    5217 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 65
    5218 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 26
    5219 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 52
    5220 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 38
    5221 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 56
    5222 Apheresis Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2019 Standard Therapy Germany 51
    5223 Apheresis Autologous Amyloidosis Hematology 2019 Standard Therapy Germany 60
    5224 Apheresis Allogeneic Aplasia Hematology 2019 Standard Therapy Poland 51
    5225 Apheresis Allogeneic Aplastic Anemia Hematology 2019 Standard Therapy Poland 16
    5226 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Poland 8
    5227 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 46
    5228 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 21
    5229 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 28
    5230 Apheresis Allogeneic B-Cell Chronic Lymphoblastic Leukemia Hematology 2019 Standard Therapy Poland 66
    5231 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2019 Standard Therapy Germany 66
    5232 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 2
    5233 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 16
    5234 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 3
    5235 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 58
    5236 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 65
    5237 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 69
    5238 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 65
    5239 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 60
    5240 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 69
    5241 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 23
    5242 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 34
    5243 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 37
    5244 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 56
    5245 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 58
    5246 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 56
    5247 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 31
    5248 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 54
    5249 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 46
    5250 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 54
    5251 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 65
    5252 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 73
    5253 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 62
    5254 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2019 Standard Therapy Germany 66
    5255 Apheresis Autologous Embryonal Cell Carcinoma Of The Testicle Hematology 2019 Standard Therapy Germany 29
    5256 Apheresis Allogeneic Extracranial Malignant Germ Cell Tumors Hematology 2019 Standard Therapy Poland 53
    5257 Apheresis Allogeneic Glanzmann Thrombasthenia Hematology 2019 Standard Therapy Poland 11
    5258 Apheresis Allogeneic High-Risk Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
    5259 Apheresis Allogeneic Histiocytosis X Hematology 2019 Standard Therapy Poland 14
    5260 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 65
    5261 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 58
    5262 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 28
    5263 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 44
    5264 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 1
    5265 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 32
    5266 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 34
    5267 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 62
    5268 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 69
    5269 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 65
    5270 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 66
    5271 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 63
    5272 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
    5273 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 68
    5274 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 65
    5275 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 54
    5276 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 64
    5277 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
    5278 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
    5279 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 71
    5280 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 63
    5281 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2019 Standard Therapy Poland 59
    5282 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2019 Standard Therapy Poland 49
    5283 Apheresis Autologous Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy Hematology 2019 Standard Therapy Germany 36
    5284 Apheresis Autologous Morbus Hodgkin Hematology 2019 Standard Therapy Germany 66
    5285 Apheresis Allogeneic Mucopolysaccharidosis Type I Metabolic 2019 Standard Therapy Poland 1
    5286 Apheresis Allogeneic Mucopolysaccharidosis Type Ii Metabolic 2019 Standard Therapy Poland 2
    5287 Apheresis Allogeneic Mucopolysaccharidosis Type Ii Metabolic 2019 Standard Therapy Poland 2
    5288 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Poland 52
    5289 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Poland 55
    5290 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
    5291 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
    5292 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
    5293 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 69
    5294 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
    5295 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
    5296 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
    5297 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 56
    5298 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 54
    5299 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 51
    5300 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57